Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Glioblastoma Multiforme Therapeutics Market Players To Expand Their Businesses With New Investments

Sunday, November 27, 2016 23:52
% of readers think this story is Fact. Add your two cents.

(Before It's News) include new market research report “Future of the Global Glioblastoma Multiforme Therapeutics Market 2015-2019 – Market Attractiveness, Competitive Landscape and Forecasts to 2021″ to its huge collection of research reports.

About Glioblastoma Multiforme

Glioblastoma multiforme is the most aggressive variant of malignant brain cancer. It has a poor prognosis with low rate of survival, a median of one year. The primary brain tumor happens due to uncontrolled cell division and developments in the brain. The tumors can be found in the glial cells or the neuron. The one which develops in the glial cells (astrocytes and oligodendrocytes) is called glioma, the commonest forms of brain tumor.

Glioblastoma multiforme is the most common variant of brain tumor, and highly invasive in nature. It may turn up in the cerebrum, mostly in the frontal and temporal lobes, and seldom spreads in areas outside the brain. The tumor progresses rapidly, and is among the most difficult-to-treat cancer with limited treatment options.

Glioblastoma multiforme can be treated by chemotherapy, steroids, radiation therapy, proton therapy, surgical procedure, and immunotherapies, which are the emerging treatment options yet to hit the market. Analysts forecast the global glioblastoma multiforme therapeutics market to grow at a CAGR of 11.94 percent during 2014-2019.

Download sample copy here @

Based on the route of administration of the drugs used to treat glioblastoma multiforme, the market is segmented as follows:

• Oral
• Parenteral

Based on the type of molecules of the drugs used to treat glioblastoma multiforme, the market is segmented as follows:

• Small Molecules
• Biologics

This report includes a discussion on the market in the following three regions:

The Americas: The major countries focused in the Americas are the US, Canada, Mexico, and Brazil

EMEA: The major countries in this region are the UK, Germany, Italy, France, Spain and Middle Eastern and African countries, such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE

APAC: The major countries in this region are Japan, China, Australia, Singapore, South Korea, and India

The vendor landscape includes a market share analysis of the major vendors along with the performances of their product portfolios. In addition, we discuss the major drivers influencing market growth and also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.

Request for discount here @

Key Regions

• Americas
• EMEA      

Key Vendors

• Arbor Pharmaceuticals
• Bristol-Myers Squibb
• Eisai
• F. Hoffmann-La Roche
• Merck 

Market Driver

• Lack of Treatment Options for Glioblastoma Multiforme
• For a full and detailed list, view our report

Contact Us :

Dhananjay Potle

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Direct :+ 1-503-894-6022

Toll Free :  + 1-800-910-6452






Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.